Company
CSA Medical
| Industry | developer of The RejuvenAir ® System, a medical device advancing liquid nitrogen spray cryotherapy for the treatment of chronic bronchitis |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| CSA Medical | Series D Financing | 2024-09-09 |
Company
| Industry | developer of The RejuvenAir ® System, a medical device advancing liquid nitrogen spray cryotherapy for the treatment of chronic bronchitis |
|---|
| Company | Round | Date |
|---|---|---|
| CSA Medical | Series D Financing | 2024-09-09 |